Evidence map›Paper›PMID 32370270›Full record

ArticleTropical medicine and infectious disease2020

Effects of Meglumine Antimoniate Treatment on Cytokine Production in a Patient with Mucosal Leishmaniasis and Chagas Diseases Co-Infection.

Karine Rezende-Oliveira, Cesar Gómez-Hernández, Marcos Vinícius da Silva, Rafael Faria de Oliveira, Juliana Reis Machado, Luciana de Almeida Silva Teixeira, Lúcio Roberto Cançado Castellano, Dalmo Correia, Virmondes Rodrigues

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Tropical medicine and infectious disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. CD4Frontiers in immunology · 2024
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Karine Rezende-OliveiraLaboratory of Biomedical Sciences, Federal University of Uberlândia, Ituiutaba, Minas Gerais CEP 38304-402, Brazil.
Cesar Gómez-HernándezLaboratory of Immunology, Federal University of Triângulo Mineiro, Uberaba, Minas Gerais CEP 38025-180, Brazil.ORCID 0000-0003-2792-8485
Marcos Vinícius da SilvaLaboratory of Parasitology, Federal University of Triângulo Mineiro, Uberaba, Minas Gerais CEP 38025-180, Brazil.
Rafael Faria de OliveiraLaboratory of Clinical Analysis, Professional Education Center, Federal University of Triângulo Mineiro, Uberaba, Minas Gerais CEP 38025-404, Brazil.
Juliana Reis MachadoDiscipline of General Pathology, Federal University of Triângulo Mineiro, Uberaba, Minas Gerais CEP 38025-200, Brazil.
Luciana de Almeida Silva TeixeiraInfectious Diseases Division, Federal University of Triângulo Mineiro, Uberaba, Minas Gerais CEP 38025-180, Brazil.
Lúcio Roberto Cançado CastellanoHuman Immunology Research and Education Group, Technical School of Health of Federal University of Paraíba, João Pessoa, Paraíba CEP 58059-900, Brazil.ORCID 0000-0003-0851-5298
Dalmo CorreiaInfectious Diseases Division, Federal University of Triângulo Mineiro, Uberaba, Minas Gerais CEP 38025-180, Brazil.
Virmondes RodriguesLaboratory of Immunology, Federal University of Triângulo Mineiro, Uberaba, Minas Gerais CEP 38025-180, Brazil.
Universidade Federal do Triângulo Mineiro · BRUniversidade Federal da Paraíba · BRUniversidade Federal de Uberlândia · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The influence of antimoniate treatment on specific anti-protozoan T-cell responses was evaluated in a 48-year-old male patient diagnosed with mucosal leishmaniasis and Chagas disease infection. Before and after treatment, PBMC (peripheral blood mononuclear cells) were cultured in the absence or presence of

Indexed as

antimoniate therapyChagas diseaseco-infectionmucosal leishmaniasis

Identifiers

PMID32370270
PMCPMC7345053
OpenAlexW3021686346

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.